Kamens Helen M, Miyamoto Jill, Powers Matthew S, Ro Kasey, Soto Marissa, Cox Ryan, Stitzel Jerry A, Ehringer Marissa A
Department of Biobehavioral Health, The Pennsylvania State University, University Park, PA 16802, USA.
Institute for Behavioral Genetics, University of Colorado, Boulder, CO 80303, USA.
Neuropharmacology. 2015 Dec;99:639-49. doi: 10.1016/j.neuropharm.2015.08.035. Epub 2015 Aug 25.
Genetic factors explain approximately half of the variance in smoking behaviors, but the molecular mechanism by which genetic variation influences behavior is poorly understood. SNPs in the putative promoter region of CHRNB3, the gene that encodes the β3 subunit of the nicotinic acetylcholine receptor (nAChR), have been repeatedly associated with nicotine behaviors. In this work we sought to identify putative function of three SNPs in the promoter region of CHRNB3 on in vitro gene expression. Additionally, we used β3 null mutant mice as a model of reduced gene expression to assess the effects on nicotine behaviors. The effect of rs13277254, rs6474413, and rs4950 on reporter gene expression was examined using a luciferase reporter assay. A major and minor parent haplotype served as the background on which alleles at the three SNPs were flipped onto different backgrounds (e.g. minor allele on major haplotype background). Constructs were tested in three human cell lines: BE(2)-C, SH-SY5Y and HEK293T. In all cell types the major haplotype led to greater reporter gene expression compared to the minor haplotype, and results indicate that this effect is driven by rs6474413. Moreover, mice lacking the β3 subunit showed reduced voluntary nicotine consumption compared that of wildtype animals. These data provide evidence that the protective genetic variant at rs6474413 identified in human genetic studies reduces gene expression and that decreased β3 gene expression in mice reduces nicotine intake. This work contributes to our understanding of the molecular mechanisms that contribute to the human genetic associations of tobacco behaviors.
遗传因素约占吸烟行为差异的一半,但基因变异影响行为的分子机制却知之甚少。编码烟碱型乙酰胆碱受体(nAChR)β3亚基的基因CHRNB3推定启动子区域中的单核苷酸多态性(SNP),一直与尼古丁行为相关。在这项研究中,我们试图确定CHRNB3启动子区域中三个SNP对体外基因表达的推定功能。此外,我们使用β3基因敲除突变小鼠作为基因表达降低的模型,来评估对尼古丁行为的影响。使用荧光素酶报告基因检测法检测了rs13277254、rs6474413和rs4950对报告基因表达的影响。一个主要和次要亲本单倍型作为背景,将三个SNP的等位基因翻转到不同背景上(例如,主要单倍型背景上的次要等位基因)。构建体在三种人类细胞系中进行了测试:BE(2)-C、SH-SY5Y和HEK293T。在所有细胞类型中,与次要单倍型相比,主要单倍型导致更高的报告基因表达,结果表明这种效应是由rs6474413驱动的。此外,缺乏β3亚基的小鼠与野生型动物相比,自愿尼古丁摄入量减少。这些数据证明,在人类基因研究中鉴定出的rs6474413处的保护性基因变异会降低基因表达,并且小鼠中β3基因表达的降低会减少尼古丁摄入量。这项工作有助于我们理解导致烟草行为人类基因关联的分子机制。